Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

USANA Health Sciences, Inc. (USNA) Profit Margins

Over the twelve months to 2026-07-04, USANA Health Sciences, Inc. (USNA) had gross margin 77.4%, operating margin -0.1%, net margin -2.4%, free cash flow margin 1.7%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-07-04 · read by EquiReason

USNAUSANA Health Sciences, Inc.Follow USNA — free
Packaged Foods · Consumer Defensive
—
Price chart with a free account
Market cap
257.9M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
3 Nov, in 10 days
LineFY2018
Dec 18
FY2019
Dec 19
FY2020
Jan 21
FY2021
Jan 22
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Jan 26
TTM
Jul 26
Trend
Gross margin83.1%82.3%81.6%81.6%80.6%80.8%81.1%78.3%77.4%
Operating margin15.8%13.8%15.6%14.3%10.8%10.1%7.8%4.0%-0.1%
Net margin10.6%9.5%11.0%9.8%6.9%6.9%4.9%1.2%-2.4%
FCF margin11.8%10.4%12.8%9.1%9.4%6.1%6.0%0.9%1.7%

USD billions · SEC XBRL

USANA Health Sciences, Inc. — questions

What is USANA Health Sciences, Inc.'s gross margin?
77.4% over the twelve months to 2026-07-04.
What is USANA Health Sciences, Inc.'s operating margin?
-0.1% over the twelve months to 2026-07-04.
What is USANA Health Sciences, Inc.'s net profit margin?
-2.4% over the twelve months to 2026-07-04.

Every figure on this page comes from USANA Health Sciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.